Karl Rickels Selected Research

Anxiety Disorders (Anxiety Disorder)

5/2019	The Course of Adverse Events in Venlafaxine XR Treatment in Generalized Anxiety Disorder.
1/2019	Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety.
1/2017	Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorder.
7/2015	Benzodiazepines in Anxiety Disorders.
1/2015	Pharmacological treatment for generalized anxiety disorder in adults: an update.
7/2014	Combined medication and CBT for generalized anxiety disorder with African American participants: reliability and validity of assessments and preliminary outcomes.
12/2013	Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.
5/2013	Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.
1/2013	Should benzodiazepines be replaced by antidepressants in the treatment of anxiety disorders? Fact or fiction?
1/2013	Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karl Rickels Research Topics

Disease

30	Anxiety Disorders (Anxiety Disorder) 05/2019 - 01/2002
15	Major Depressive Disorder (Major Depressive Disorders) 05/2013 - 10/2004
5	Weight Gain 01/2018 - 01/2006
5	Premenstrual Syndrome (Premenstrual Tension) 12/2011 - 10/2002
3	Panic Disorder (Panic Attack) 08/2018 - 10/2003
3	Mental Disorders (Mental Disorder) 01/2018 - 08/2004
3	Insulin Resistance 01/2018 - 09/2013
3	Sleepiness 03/2009 - 12/2007
2	Obesity 01/2018 - 09/2013
2	Premenstrual Dysphoric Disorder 12/2011 - 02/2004
2	Medically Unexplained Symptoms 03/2010 - 09/2005
2	Nausea 03/2009 - 01/2008
1	Depressive Disorder (Melancholia) 01/2018
1	Hyperinsulinism (Hyperinsulinemia) 01/2018
1	Metabolic Diseases (Metabolic Disease) 10/2015
1	Constipation 01/2012
1	Diarrhea 03/2009
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2008
1	Dizziness (Lightheadedness) 01/2008
1	Disorders of Excessive Somnolence (Hypersomnia) 12/2007
1	Fatigue 12/2007
1	Social Phobia 10/2004
1	Psychomotor Disorders 07/2004

Drug/Important Bio-Agent (IBA)

11	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 05/2019 - 10/2004
11	Antidepressive Agents (Antidepressants)IBA 01/2019 - 10/2002
10	BenzodiazepinesIBA 01/2019 - 10/2003
6	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2015 - 02/2004
5	Sertraline (Zoloft)FDA LinkGeneric 12/2011 - 02/2004
3	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 09/2013
3	Olanzapine (Zyprexa)FDA Link 01/2018 - 09/2013
3	Serotonin (5 Hydroxytryptamine)IBA 01/2015 - 08/2004
3	Vilazodone HydrochlorideIBA 10/2012 - 03/2009
3	Pregabalin (Lyrica)FDA Link 05/2012 - 09/2005
3	Paroxetine (Paxil)FDA LinkGeneric 01/2006 - 04/2003
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 09/2013
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2015 - 09/2013
2	Insulin (Novolin)FDA Link 10/2015 - 09/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2015 - 10/2004
2	Aripiprazole (Abilify)FDA Link 09/2013 - 01/2012
2	ziprasidone (Geodon)FDA Link 04/2010 - 10/2005
2	Desvenlafaxine Succinate FDA Link 02/2010 - 08/2008
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2006 - 09/2005
2	Alprazolam (Xanax)FDA LinkGeneric 09/2005 - 07/2004
1	Pharmaceutical PreparationsIBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 12/2013
1	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 12/2013
1	Hormones (Hormone)IBA 09/2013
1	Glucagon (Glukagon)FDA Link 09/2013
1	antiarrhythmic peptide (AAP)IBA 09/2013
1	Opioid Analgesics (Opioids)IBA 05/2013
1	5-methyltetrahydrofolateIBA 12/2012
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 06/2012
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 05/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2011
1	Prostaglandins BIBA 03/2010
1	Fluoxetine (Prozac)FDA LinkGeneric 09/2008
1	Quetiapine Fumarate (Seroquel)FDA Link 09/2008
1	5-HT1A Serotonin ReceptorIBA 04/2008
1	naluzotanIBA 04/2008
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2008
1	Modafinil (Provigil)FDA Link 12/2007
1	Selegiline (E250)FDA LinkGeneric 09/2006
1	Serotonin ReceptorsIBA 01/2006
1	GABA Uptake InhibitorsIBA 11/2005
1	Tiagabine (Gabitril)FDA Link 11/2005
1	gamma-Aminobutyric Acid (GABA)IBA 11/2005
1	Buspirone (Buspar)FDA LinkGeneric 10/2003
1	Imipramine (Janimine)FDA LinkGeneric 10/2003
1	Pregnanolone (Allopregnanolone)IBA 10/2002

Therapy/Procedure

5	Therapeutics 05/2012 - 10/2003
4	Drug Therapy (Chemotherapy) 05/2013 - 01/2002
1	Secondary Prevention 05/2019
1	Duration of Therapy 05/2009